Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians

被引:0
作者
Ma, Jinlan [2 ]
Li, Yan [3 ]
Zhou, Fang [2 ]
Xu, Xiaoyi [2 ]
Guo, Gang
Qu, Yi [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Hlth Care, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250012, Shandong, Peoples R China
[3] Shandong Prov Hosp, Dept Ophthalmol, Jinan, Peoples R China
来源
MOLECULAR VISION | 2012年 / 18卷 / 248期
关键词
PPAR-GAMMA GENE; IMPROVED INSULIN SENSITIVITY; BODY-MASS INDEX; DECREASED RISK; PPAR-GAMMA-2; GENE; MISSENSE MUTATION; MELLITUS; VARIANT; IDENTIFICATION; SUBSTITUTION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma 2 (PPAR gamma 2) gene is reported to be associated with diabetes. However, the gene's association with diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) has been investigated in numerous epidemiologic studies with controversial results. This meta-analysis aimed to collectively assess the association of the Pro12Ala polymorphism with DR in T2DM. Methods: An electronic literature search was conducted on PubMed, ISI Web of Knowledge, EMBASE, and the China National Knowledge Internet. A dominant model [(Pro/Ala + Ala/Ala) versus Pro/Pro] was used to ensure adequate statistical power. Crude odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using the fixed effect model. Potential sources of heterogeneity and bias were explored. Results: This meta-analysis included genotype data from 2,720 cases with DR and 2,450 controls free of DR from eight eligible publications. The results showed the Ala allele had a protective effect on DR in T2DM (OR=0.81; 95% CI: 0.68-0.98, p=0.03). There was no significant evidence against homogeneity (I-2=46%, P-heterogeneity=0.07). The sensitivity analysis showed a robust association of the Pro12Ala polymorphism with DR in T2DM after a study involving Caucasians that presented a big effect on heterogeneity (OR=0.75; 95% CI: 0.62-0.91, p=0.003) was excluded. Possible ethnic differences in the association of the Pro12Ala single nucleotide polymorphism and DR were demonstrated; a significant association was illustrated in the Caucasian subgroup (OR=0.74; 95% CI: 0.59-0.94, p=0.01) but was not found in the Asian subgroup (OR=0.77; 95% CI: 0.55-1.07, p=0.12). No publication bias was observed. Conclusions: This meta-analysis suggested a significant association exists between the Pro12Ala polymorphism and DR in T2DM with ethnic differences. The Ala allele had a significant protective effect against DR in T2DM.
引用
收藏
页码:2352 / 2360
页数:9
相关论文
共 34 条
  • [1] The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
    Altshuler, D
    Hirschhorn, JN
    Klannemark, M
    Lindgren, CM
    Vohl, MC
    Nemesh, J
    Lane, CR
    Schaffner, SF
    Bolk, S
    Brewer, C
    Tuomi, T
    Gaudet, D
    Hudson, TJ
    Daly, M
    Groop, L
    Lander, ES
    [J]. NATURE GENETICS, 2000, 26 (01) : 76 - 80
  • [2] Peroxisome proliferator-activated receptor γ:: the more the merrier?
    Argmann, CA
    Cock, TA
    Auwerx, J
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (02) : 82 - 92
  • [3] The Ala allele in the PPAR-γ2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects
    Boas Huguenin, Grazielle Vilas
    Rosa, Glorimar
    [J]. BRITISH JOURNAL OF NUTRITION, 2010, 104 (04) : 488 - 497
  • [4] The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes
    Caramori, ML
    Canani, LH
    Costa, LA
    Gross, JL
    [J]. DIABETES, 2003, 52 (12) : 3010 - 3013
  • [5] Characterization of a Novel Polymorphism in PPARG Regulatory Region Associated with Type 2 Diabetes and Diabetic Retinopathy in Italy
    Costa, Valerio
    Casamassimi, Amelia
    Esposito, Katherine
    Villani, Angela
    Capone, Mariaelena
    Iannella, Rosa
    Schisano, Bruno
    Ciotola, Miryam
    Di Palo, Carmen
    Corrado, Feliciantonia Capone
    Santangelo, Franco
    Giugliano, Dario
    Ciccodicola, Alfredo
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2009,
  • [6] A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
    Deeb, SS
    Fajas, L
    Nemoto, M
    Pihlajamäki, J
    Mykkänen, L
    Kuusisto, J
    Laakso, M
    Fujimoto, W
    Auwerx, J
    [J]. NATURE GENETICS, 1998, 20 (03) : 284 - 287
  • [7] Be fit or be sick: Peroxisome proliferator-activated receptors are down the road
    Desvergne, B
    Michalik, L
    Wahli, W
    [J]. MOLECULAR ENDOCRINOLOGY, 2004, 18 (06) : 1321 - 1332
  • [8] Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2):: divergent modulating effects on body mass index in obese and lean Caucasian men
    Ek, J
    Urhammer, SA
    Sorensen, TIA
    Andersen, T
    Auwerx, J
    Pedersen, O
    [J]. DIABETOLOGIA, 1999, 42 (07) : 892 - 895
  • [9] Peroxisome proliferator-activated receptor-γ2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes -: The Berlin Diabetes Mellitus (BeDiaM) Study
    Herrmann, SM
    Ringel, J
    Wang, JG
    Staessen, JA
    Brand, E
    [J]. DIABETES, 2002, 51 (08) : 2653 - 2657
  • [10] Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: A meta-analysis
    Huang, Xiao
    Zhao, Jiangpei
    Zhao, Tongfeng
    [J]. ATHEROSCLEROSIS, 2011, 215 (01) : 136 - 144